BeStock  

Astrana Health ASTH

US equityMarket cap rank #2902Medical Care Facilities
$28.90 +$0.22 (+0.77%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $28.90 0.00%
Open$28.52
Prev close$28.68
Day range$28.33 – $29.75
Volume441.0K
Market cap$1.44B
P/E (TTM)26.8
Dividend yield–

ASTH Stock News

Headlines matching Astrana Health or the ASTH ticker, most recent first.

  • Truist Financial Maintains Astrana Health(ASTH.US) With Buy RatingMarket news · 29 Sep 2026 · Direct mention
  • Oppenheimer Initiates Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $53Market news · 15 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Astrana Health(ASTH.US), With a Forecast Between $41 to $53Market news · 8 Aug 2026 · Direct mention
  • Barclays Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $53Market news · 28 Aug 2026 · Direct mention
  • Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $55Market news · 11 Aug 2026 · Direct mention
  • Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $55Market news · 11 Aug 2026 · Direct mention
  • BTIG Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $65Market news · 10 Aug 2026 · Direct mention
  • TD Cowen Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $50Market news · 14 Jul 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Oruka Therapeutics (ORKA), Alto Neuroscience, Inc. (ANRO) and Astrana Health (ASTH)TipRanks · 14 Jul 2026 · Direct mention
  • BTIG Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $65 PositiveMarket news · 14 Jul 2026 · Direct mention
  • TD Cowen Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $50 PositiveMarket news · 14 Jul 2026 · Direct mention
  • Analysts Are Bullish on These Healthcare Stocks: Astrana Health (ASTH), ArriVent BioPharma, Inc. (AVBP) PositiveTipRanks · 14 Jul 2026 · Direct mention
  • Jefferies Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $53 PositiveMarket news · 30 Jun 2026 · Direct mention
  • BTIG Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $50 PositiveMarket news · 2 Jun 2026 · Direct mention
  • Barclays Upgrades Astrana Health(ASTH.US) to Buy Rating, Raises Target Price to $50 PositiveMarket news · 26 May 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on ASTH.

Sign in to join the discussion.

Scroll to Top